Summary of ASP Isotopes FY Conference Call Company Overview - **Company**: ASP Isotopes (NasdaqCM:ASPI) - **CEO**: Paul Mann - **Date of Conference**: March 12, 2026 Industry Context - **Helium Shortage**: A significant helium shortage is impacting semiconductor production and other industries, with 25%-30% of the world's helium supply currently offline due to production issues in Qatar [3][5][6]. - **Production Rates**: Current helium production is at approximately 4.5 billion cubic feet (BCF) annually, while demand is around 6.5 BCF, indicating a supply-demand gap [5]. Key Points on Helium Supply - **Geopolitical Factors**: The closure of the Strait of Hormuz and damage to Qatar's LNG facility have exacerbated the helium supply crisis [6]. - **ASP Isotopes' Role**: ASP Isotopes owns Renergen, which is expected to be one of the largest helium producers by the end of the decade. The company is currently in phase one of its helium liquefied natural gas plant build-out [6][7]. - **Production Capacity**: Phase one is projected to produce about 58 thousand cubic feet (MCF) of helium per day, with potential revenues of $8 million annually at current helium prices [10][12]. Financial Projections - **Revenue Estimates**: Combined annualized revenue from helium and LNG is estimated at $20 million, with gross profits around $5 million. Higher helium prices could significantly increase profits [10][11][12]. - **Government Support**: The U.S. government has deemed ASP's helium facilities critical, committing $500 million to phase two of the project [11][12]. Isotope Production Updates - **Silicon-28**: Initial samples shipped in August 2025 have been confirmed for quality. The plant is set to restart soon after implementing safety and efficiency improvements [21][23]. - **Carbon-14**: Feedstock from Canada is expected imminently, with production anticipated to start within 60-90 days [24][25]. - **Ytterbium-176**: Production is currently limited due to a laser failure, but operations are expected to ramp up to commercial volumes soon [28][29]. Regulatory and Strategic Developments - **Regulatory Advancements**: ASP has signed a service level agreement with the South African Nuclear Energy Corporation, allowing for uranium enrichment at an existing facility [34][35]. - **Partnerships**: Collaboration with TerraPower for uranium enrichment is ongoing, with a focus on meeting timelines for reactor fuel supply [38]. Strategic Vision - **Integration of Operations**: The acquisition of Renergen is seen as a strategic move to create a comprehensive electronic gases company, integrating helium production with semiconductor and medical isotope operations [40][41][42]. - **Future Growth**: ASP Isotopes aims to become a low-cost producer of isotopes by exploring locations with cheap energy for new plants, including Iceland and North America [52][53]. Conclusion - ASP Isotopes is positioned to play a critical role in addressing the helium supply crisis while expanding its isotope production capabilities. The company's strategic acquisitions and partnerships are aimed at enhancing its market position in the semiconductor and medical isotope sectors.